Reference data : LOINC code

Filter


Clear filter

Results
104,672 results found
Loinc Number Component Property System Time aspect ScaleType MethodType Relat_nms loincStatus Long Common name answerList chngType DefinitionDescription dtLastCh exactCmspy exampleUnits exmplAnswers externalCopyrightNotice formula hl7FieldSubfieldId InpcPercentage ipccUnits loincClass loincFinal loincNum mapTo methodTyp molarMass naaccrId orderObs panelElements reference scope setRoot shortName source surveyQuestSrc surveyQuestText unitsRequired acssym relatedNames2 VersionLastChanged VersionFirstRelease ValidHL7AttachmentRequest PanelType AssociatedObservations EXTERNAL_COPYRIGHT_LINK HL7_ATTACHMENT_STRUCTURE CONSUMER_NAME EXAMPLE_UCUM_UNITS STATUS_REASON STATUS_TEXT CHANGE_REASON_PUBLIC COMMON_TEST_RANK COMMON_ORDER_RANK
99751-0 Satisfaction level with length of time for vision improvement after LASIK Find ^Patient Pt Ord     ACTIVE Satisfaction level with length of time for vision improvement after LASIK   ADD DefinitionDescription                   SURVEY.PROWL   99751-0         Observation       0         N   Finding; Findings; Len; Levels; Levl; LV; LVL; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey 2.72 2.72                       0
99752-8 Satisfaction level with length of time it took for improvement in post-operative discomfort after LASIK Find ^Patient Pt Ord     ACTIVE Satisfaction level with length of time it took for improvement in post-operative discomfort after LASIK   ADD DefinitionDescription                   SURVEY.PROWL   99752-8         Observation       0         N   After; Finding; Findings; Len; Levels; Levl; LV; LVL; Ordinal; Point in time; PST; QL; Qual; Qualitative; Random; Screen; Survey 2.72 2.72                       0
99753-6 Level of understanding risk and benefit of LASIK before treatment Find ^Patient Pt Ord     ACTIVE Level of understanding risk and benefit of LASIK before treatment   ADD DefinitionDescription                   SURVEY.PROWL   99753-6         Observation       0         N   Finding; Findings; Levels; Levl; LV; LVL; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; Tx 2.72 2.72                       0
99754-4 When not wearing corrective lenses, distance vision is as good as anticipated after LASIK Find ^Patient Pt Ord     ACTIVE When not wearing corrective lenses, distance vision is as good as anticipated after LASIK   ADD DefinitionDescription                   SURVEY.PROWL   99754-4         Observation       0         N   Arterial Stenosis; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey 2.72 2.72                       0
99755-1 Wear corrective lenses to see in the distance Find ^Patient Pt Ord     ACTIVE Wear corrective lenses to see in the distance   ADD DefinitionDescription                   SURVEY.PROWL   99755-1         Observation       0         N   Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey 2.72 2.72                       0
99756-9 Goal for LASIK achieved Find ^Patient Pt Ord     ACTIVE Goal for LASIK achieved   ADD DefinitionDescription                   SURVEY.PROWL   99756-9         Observation       0         N   Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey 2.72 2.72                       0
99757-7 Happiness level of having LASIK Find ^Patient Pt Ord     ACTIVE Happiness level of having LASIK   ADD DefinitionDescription                   SURVEY.PROWL   99757-7         Observation       0         N   Finding; Findings; Levels; Levl; LV; LVL; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey 2.72 2.72                       0
99759-3 Would recommend LASIK to friend or family member Find ^Patient Pt Ord     ACTIVE Would recommend LASIK to friend or family member   ADD DefinitionDescription                   SURVEY.PROWL   99759-3         Observation       0         N   Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey 2.72 2.72                       0
9976-2 QRS terminal amplitude.lead I Elpot Heart Pt Qn EKG   ACTIVE QRS terminal amplitude in lead I   MIN DefinitionDescription     mV             EKG.MEAS   9976-2   EKG     Observation       0 QRS T-Amp L-I       Y   Cardiac; Cardio; Cardiology; ECG; EKG.MEASUREMENTS; Electrical potential; Electrocardiogram; Electrocardiograph; Heart Disease; Hrt; Painter's colic; PB; Plumbism; Point in time; QNT; QRS T-Amp L-I; Quan; Quant; Quantitative; Random; Voltage 2.48 1.0i               mV       0
99760-1 Reason not to have or recommend LASIK Find ^Patient Pt Ord     ACTIVE Reason not to have or recommend LASIK   ADD DefinitionDescription                   SURVEY.PROWL   99760-1         Observation       0         N   Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey 2.72 2.72                       0
99761-9 Clot initiation.kaolin induced Time Bld Pt Qn Thromboelastography.resonance   ACTIVE Clot initiation.kaolin induced [Time] in Blood by Resonance TEG   MIN DefinitionDescription     min             COAG   99761-9   Thromboelastography.resonance     Observation       0 Clot init kao ind p hep neut Bld Res TEG       N   Blood; Clot init kao ind p hep neut; Clot init kaolin ind; COAGULATION; CT; Point in time; QNT; Quan; Quant; Quantitative; Random; Res TEG; TEG; Thrombelastography; Thrombelastometry; WB; Whole blood 2.75 2.72               min       0
99762-7 Clot angle.kaolin induced Angle Bld Pt Qn Thromboelastography.resonance   ACTIVE Clot angle.kaolin induced in Blood by Resonance TEG   ADD DefinitionDescription     degrees             COAG   99762-7   Thromboelastography.resonance     Observation       0 Clot angle.kaolin induced Bld Res TEG       N   Blood; COAGULATION; Point in time; QNT; Quan; Quant; Quantitative; Random; Res TEG; TEG; Thrombelastography; Thrombelastometry; WB; Whole blood 2.72 2.72               deg       0
99763-5 Clot formation.kaolin induced Time Bld Pt Qn Thromboelastography.resonance   ACTIVE Clot formation.kaolin induced [Time] in Blood by Resonance TEG   ADD DefinitionDescription     min             COAG   99763-5   Thromboelastography.resonance     Observation       0 CFT form kaolin ind Bld Res TEG       N   Activated clotting time; Blood; CFT; CFT form kaolin ind; Clot time; COAGULATION; Kinetics; k-time; Point in time; QNT; Quan; Quant; Quantitative; Random; Res TEG; TEG; Thrombelastography; Thrombelastometry; WB; Whole blood 2.72 2.72               min       0
99764-3 Interferon.gamma MCnc CSF Pt Qn     ACTIVE Interferon gamma [Mass/volume] in Cerebral spinal fluid   ADD DefinitionDescription     pg/ml             HEM/BC   99764-3         Both       0 IGNF CSF-mCnc       N   Cerebral spinal fluid; Cerebrospinal Fl; G-INF; HEMATOLOGY/CELL COUNTS; IFN; IGNF; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid 2.72 2.72               pg/mL       0
99765-0 Interleukin 12 MCnc CSF Pt Qn     ACTIVE Interleukin 12 [Mass/volume] in Cerebral spinal fluid   ADD DefinitionDescription     pg/ml             CHEM   99765-0         Both       0 Il12 CSF-mCnc       N   Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Edodekin Alfa; IL; IL12; IL-12; Level; Mass concentration; Natural Killer Cell Stimulatory Factor; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid 2.72 2.72               pg/mL       0
99766-8 Interleukin 17 MCnc CSF Pt Qn     ACTIVE Interleukin 17 [Mass/volume] in Cerebral spinal fluid   ADD DefinitionDescription     pg/ml             CHEM   99766-8         Both       0 IL-17 CSF-mCnc       N   Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; IL; IL-17; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid 2.72 2.72               pg/mL       0
99767-6 Interleukin 1 beta MCnc CSF Pt Qn     ACTIVE Interleukin 1 beta [Mass/volume] in Cerebral spinal fluid   ADD DefinitionDescription     pg/ml             CHEM   99767-6         Both       0 Il1Beta CSF-mCnc       N   B; Cerebral spinal fluid; Cerebrospinal Fl; CG Antigen-Specific Helper Factor; Chemistry; Epidermal Cell Derived Thymocyte-Activating Factor; ETAF; i; IL; IL1; IL-1; IL-1B; Il1Beta; IL-1Ã?²; Level; Lymphocyte-Activating Factor; Lymphocyte-Stimulating Hormone; Macrophage Cell Factor; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; T Helper Factor 2.72 2.72               pg/mL       0
99768-4 Interleukin 2 receptor.soluble MCnc CSF Pt Qn     ACTIVE Interleukin 2 Receptor Soluble [Mass/volume] in Cerebral spinal fluid   ADD DefinitionDescription     pg/ml             CHEM   99768-4         Both       0 Sol Il2 Recep CSF-mCnc       N   Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Costimulator; II; IL; IL2; IL-2; IL2R; IL-2R; Il2Recep; ILR2; Level; Lymphocyte Mitogenic Factor; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Rec; Recept; Receptors; Recp; Recptr; sIL-2R; Sol Il2 Recep; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; T-Cell Growth Factor; T-Cell Stimulating Factor; TCGF; Thymocyte Stimulating Factor 2.72 2.72               pg/mL       0
99769-2 Interleukin 8 MCnc CSF Pt Qn     ACTIVE Interleukin 8 [Mass/volume] in Cerebral spinal fluid   ADD DefinitionDescription     pg/ml             CHEM   99769-2         Both       0 Il8 CSF-mCnc       N   Anionic Neutrophil-Activating Peptide; Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Chemotactic Factor, Macrophage-Derived; Chemotactic Factor, Neutrophil; Chemotactic Factor, Neutrophil, Monocyte-Derived; IL; Il8; IL-8; Leukocyte Adhesion Inhibitor; Level; Mass concentration; Neutrophil Activation Factor; Neutrophil-Activating Peptide, Lymphocyte-Derived; Neutrophil-Activating Peptide, Monocyte-Derived; Neutrophil-Activating Peptides, Fibroblast-Derived; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid 2.72 2.72               pg/mL       0
9977-0 QRS terminal amplitude.lead II Elpot Heart Pt Qn EKG   ACTIVE QRS terminal amplitude in lead II   MIN DefinitionDescription     mV             EKG.MEAS   9977-0   EKG     Observation       0 QRS T-Amp L-II       Y   2; Cardiac; Cardio; Cardiology; ECG; EKG.MEASUREMENTS; Electrical potential; Electrocardiogram; Electrocardiograph; Heart Disease; Hrt; Painter's colic; PB; Plumbism; Point in time; QNT; QRS T-Amp L-II; Quan; Quant; Quantitative; Random; Voltage 2.48 1.0i               mV       0
99770-0 Tumor necrosis factor.alpha MCnc CSF Pt Qn     ACTIVE Tumor necrosis factor.alpha [Mass/volume] in Cerebral spinal fluid   ADD DefinitionDescription     pg/ml             CHEM   99770-0         Both       0 A-Tumor Necrosis Fact CSF-mCnc       N   Alfa; A-Tumor Necrosis Fact; Cachectin; Cachectine; Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Fac; Fact; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; TNF 2.72 2.72               pg/mL       0
99771-8 SARS coronavirus 2 spike & nucleocapsid protein stimulated gamma interferon panel - Bld Pt -     ACTIVE SARS coronavirus 2 spike and nucleocapsid protein stimulated gamma interferon panel - Blood   ADD DefinitionDescription                   PANEL.MICRO   99771-8         Order       0 SARS-CoV-2 IGRA Spk+Nuclcp Pnl Bld       N   2019 Novel Coronavirus; 2019-nCoV; Blood; Corona virus; COVID19; COVID-19; ID; IFN; IGRA; II; Infectious Disease; InfectiousDisease; Microbiology; Pan; PANEL.MICROBIOLOGY; Panl; Pnl; Point in time; PR; Prot; Random; SARS Coronavirus 1; SARS-CoV; SARS-CoV-1; SARS-CoV-2; SARS-CoV-2 IGRA Spk+Nuclcp Pnl; Severe Acute Respiratory Syndrome; Viral Pneumonias; WB; Whole blood; Wuhan coronavirus 2.72 2.72   Panel                   0
99772-6 SARS coronavirus 2 stimulated gamma interferon Imp Bld Pt Ord     ACTIVE SARS-CoV-2 stimulated gamma interferon [Interpretation] in Blood Qualitative   ADD DefinitionDescription                   MICRO   99772-6         Observation       0 SARS-CoV-2 IFN-g Bld-Imp       N   2019 Novel Coronavirus; 2019-nCoV; Blood; Corona virus; COVID19; COVID-19; ID; IFN; IGRA; II; Impression; Impression/interpretation of study; Impressions; Infectious Disease; InfectiousDisease; Interp; Interpretation; Microbiology; Ordinal; Point in time; QL; Qual; Qualitative; Random; SARS Coronavirus 1; SARS-CoV; SARS-CoV-1; SARS-CoV-2; SARS-CoV-2 IFN-g; Screen; Severe Acute Respiratory Syndrome; Viral Pneumonias; WB; Whole blood; Wuhan coronavirus 2.72 2.72                       0
99773-4 SARS coronavirus 2 stimulated gamma interferon release by T-cells.Spike Ag spot count^^corrected for background Num Bld Pt Qn     ACTIVE SARS coronavirus 2 stimulated gamma interferon release by T-cells.Spike Ag spot count [#] corrected for background in Blood   ADD DefinitionDescription     #             MICRO   99773-4         Observation       0 SARSCoV2 IGRA Spike Ct bckgrd cor Bld       N   2019 Novel Coronavirus; 2019-nCoV; bckgrd cor; Blood; Cell; Cellularity; Cnt; Corona virus; Count; COVID19; COVID-19; ID; IFN; IGRA; II; Infectious Disease; InfectiousDisease; Microbiology; Number; Point in time; QNT; Quan; Quant; Quantitative; Random; SARS Coronavirus 1; SARS-CoV; SARS-CoV-1; SARS-CoV-2; SARS-CoV-2 IFN-g; SARS-CoV-2 IFN-g T cells; SARSCoV2 IGRA Spike Ct; Severe Acute Respiratory Syndrome; T prime; Viral Pneumonias; WB; Whole blood; Wuhan coronavirus 2.72 2.72               {#}       0
99774-2 SARS coronavirus 2 stimulated gamma interferon release by T-cells.Nucleocapsid Ag spot count^^corrected for background Num Bld Pt Qn     ACTIVE SARS coronavirus 2 stimulated gamma interferon release by T-cells.Nucleocapsid Ag spot count [#] corrected for background in Blood   ADD DefinitionDescription     #             MICRO   99774-2         Observation       0 SARSCoV2 IGRA Nucpsid Ct bckgrd cor Bld       N   2019 Novel Coronavirus; 2019-nCoV; bckgrd cor; Blood; Cell; Cellularity; Cnt; Corona virus; Count; COVID19; COVID-19; ID; IFN; IGRA; II; Infectious Disease; InfectiousDisease; Microbiology; Number; Point in time; QNT; Quan; Quant; Quantitative; Random; SARS Coronavirus 1; SARS-CoV; SARS-CoV-1; SARS-CoV-2; SARS-CoV-2 IFN-g; SARS-CoV-2 IFN-g T cells; Severe Acute Respiratory Syndrome; T prime; Viral Pneumonias; WB; Whole blood; Wuhan coronavirus 2.72 2.72               {#}       0
104,672 results found